Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,582 | 547 | 100.0% |
| Education | $1.09 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,895 | 85 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,782 | 125 | $0 (2022) |
| CSL Behring | $1,421 | 71 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $903.56 | 28 | $0 (2022) |
| OptiNose US, Inc. | $592.51 | 39 | $0 (2022) |
| Genentech USA, Inc. | $503.62 | 28 | $0 (2022) |
| Shire North American Group Inc | $501.74 | 25 | $0 (2019) |
| BioCryst US Sales Co., LLC | $407.92 | 23 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $347.33 | 16 | $0 (2022) |
| Pharming Healthcare, Inc. | $296.51 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $44.60 | 2 | CSL Behring ($25.27) |
| 2022 | $1,742 | 83 | CSL Behring ($329.35) |
| 2021 | $2,026 | 105 | CSL Behring ($388.09) |
| 2020 | $1,250 | 69 | GlaxoSmithKline, LLC. ($353.15) |
| 2019 | $2,335 | 117 | AstraZeneca Pharmaceuticals LP ($541.83) |
| 2018 | $1,898 | 93 | AstraZeneca Pharmaceuticals LP ($566.85) |
| 2017 | $1,287 | 79 | GlaxoSmithKline, LLC. ($357.49) |
All Payment Transactions
548 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2023 | CSL Behring | Kcentra (Biological), Haegarda | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 01/27/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Respiratory | ||||||
| 12/20/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/14/2022 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Immunology | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Respiratory | ||||||
| 12/06/2022 | CSL Behring | Haegarda (Biological), Kcentra | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Immunology | ||||||
| 12/06/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Immunology | ||||||
| 11/30/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Respiratory | ||||||
| 11/29/2022 | CSL Behring | Haegarda (Biological), Kcentra | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Immunology | ||||||
| 11/17/2022 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 11/16/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/15/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/09/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Immunology | ||||||
| 10/29/2022 | CSL Behring | Kcentra (Biological), Haegarda | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/19/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/19/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2022 | CSL Behring | Haegarda (Biological), Kcentra | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Immunology | ||||||
| 10/11/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/06/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $91.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/04/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Inflammation | ||||||
| 09/28/2022 | Covis Pharma GmBH | ALVESCO (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Respiratory | ||||||
| 09/21/2022 | CSL Behring | Haegarda (Biological), Kcentra | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Immunology | ||||||
| 09/20/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Immunology | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 136 | 1,082 | $37,898 | $15,463 |
| 2021 | 6 | 187 | 1,915 | $54,527 | $23,788 |
| 2020 | 7 | 206 | 1,393 | $47,606 | $17,607 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 145 | $19,590 | $9,415 | 48.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 17 | 825 | $9,900 | $2,978 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $5,400 | $2,295 | 42.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 17 | 94 | $3,008 | $774.58 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 127 | $17,145 | $8,957 | 52.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $9,600 | $4,215 | 43.9% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 21 | 1,101 | $13,212 | $4,078 | 30.9% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 12 | 218 | $4,360 | $2,961 | 67.9% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 23 | 215 | $6,880 | $1,911 | 27.8% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 14 | 222 | $3,330 | $1,666 | 50.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 136 | $18,360 | $7,122 | 38.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $8,700 | $3,674 | 42.2% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 19 | 877 | $10,524 | $3,273 | 31.1% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 12 | 150 | $3,000 | $1,796 | 59.9% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 22 | 171 | $5,472 | $1,211 | 22.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 13 | 14 | $910.00 | $344.84 | 37.9% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2020 | 14 | 16 | $640.00 | $186.37 | 29.1% |
About Lee Sonin
Lee Sonin is a Allergy healthcare provider based in Schaumburg, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376571497.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lee Sonin has received a total of $10,583 in payments from pharmaceutical and medical device companies, with $44.60 received in 2023. These payments were reported across 548 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($10,582).
As a Medicare-enrolled provider, Sonin has provided services to 529 Medicare beneficiaries, totaling 4,390 services with total Medicare billing of $56,858. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Practice Information
- Specialty Allergy
- Location Schaumburg, IL
- Active Since 06/29/2006
- Last Updated 12/27/2021
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1376571497
Products in Payments
- NUCALA (Biological) $1,044
- FASENRA (Drug) $813.13
- DUPIXENT (Biological) $720.01
- Haegarda (Biological) $595.23
- Xhance (Drug) $592.51
- Kcentra (Biological) $507.64
- Xolair (Biological) $503.62
- SYMBICORT (Drug) $465.04
- TAKHZYRO (Biological) $409.90
- BREO (Drug) $362.00
- TRELEGY ELLIPTA (Drug) $352.52
- ALVESCO (Drug) $344.99
- RUCONEST (Biological) $296.51
- FASENRA (Biological) $276.03
- Orladeyo (Drug) $238.07
- DUPIXENT DUPILUMAB INJECTION (Biological) $220.87
- ORLADEYO (Drug) $194.21
- SPIRIVA RESPIMAT (Drug) $180.89
- FIRAZYR (Drug) $160.64
- EUCRISA (Drug) $152.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.